We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $812M
1-Year Est. Return 29.76%
This Fund
S&P 500
This Quarter Est. Return
+17.64%
1 Year Est. Return
+29.76%
3 Year Est. Return
+77.21%
5 Year Est. Return
+92.54%
10 Year Est. Return
+280.51%
AUM
$260M
AUM Growth
+$51.9M
Cap. Flow
+$17.3M
Cap. Flow %
6.65%
Top 10 Hldgs %
33.65%
Holding
129
New
12
Increased
42
Reduced
49
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 19.87%
2 Technology 13.03%
3 Consumer Staples 12.04%
4 Financials 9.76%
5 Communication Services 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIS icon
26
Walt Disney
DIS
$170B
$3.15M 1.21%
28,237
-577
-2% -$63.7K
ABT icon
27
Abbott
ABT
$185B
$3.11M 1.19%
34,042
-300
-0.9% -$27.1K
SCHM icon
28
Schwab US Mid-Cap ETF
SCHM
$14.7B
$3.08M 1.18%
175,860
+4,095
+2% +$66.7K
T icon
29
AT&T
T
$162B
$3.06M 1.17%
133,823
+9,315
+7% +$212K
EEFT icon
30
Euronet Worldwide
EEFT
$2.8B
$2.9M 1.11%
30,255
+4,350
+17% +$402K
SCHA icon
31
Schwab U.S Small- Cap ETF
SCHA
$22.7B
$2.79M 1.07%
171,076
+3,432
+2% +$51.4K
IBM icon
32
IBM
IBM
$213B
$2.47M 0.95%
21,403
+7,015
+49% +$815K
STZ icon
33
Constellation Brands
STZ
$22.4B
$2.45M 0.94%
14,016
+114
+0.8% +$19K
DGX icon
34
Quest Diagnostics
DGX
$25.6B
$2.42M 0.93%
21,225
CERN
35
DELISTED
Cerner Corp
CERN
$2.4M 0.92%
35,075
-1,284
-4% -$88.2K
CTSH icon
36
Cognizant
CTSH
$24.9B
$2.37M 0.91%
41,664
+3,100
+8% +$167K
TFC icon
37
Truist Financial
TFC
$63.4B
$2.35M 0.9%
62,660
-825
-1% -$29.7K
NVO
38
Novo Nordisk
NVO
$208B
$2.3M 0.88%
70,328
+5,400
+8% +$172K
AMZN icon
39
Amazon
AMZN
$3.06T
$2.25M 0.86%
16,280
+2,240
+16% +$271K
JPM icon
40
JPMorgan Chase
JPM
$937B
$2.24M 0.86%
23,785
+4,523
+23% +$429K
V icon
41
Visa
V
$683B
$2.23M 0.85%
11,526
+1,643
+17% +$300K
MCD icon
42
McDonald's
MCD
$188B
$2.22M 0.85%
12,033
GSK icon
43
GSK
GSK
$103B
$2.17M 0.83%
42,584
+2,532
+6% +$130K
MMM icon
44
3M
MMM
$91.4B
$2.11M 0.81%
16,185
-150
-0.9% -$18.9K
EMR icon
45
Emerson Electric
EMR
$86.7B
$2.09M 0.8%
33,754
+426
+1% +$24.2K
GILD icon
46
Gilead Sciences
GILD
$163B
$1.95M 0.75%
25,395
-155
-0.6% -$11.9K
SYY icon
47
Sysco
SYY
$40.7B
$1.93M 0.74%
35,320
-860
-2% -$45.2K
SCHW
48
Charles Schwab
SCHW
$184B
$1.91M 0.73%
56,466
+689
+1% +$24.7K
KO icon
49
Coca-Cola
KO
$374B
$1.81M 0.69%
40,494
+1,835
+5% +$84.5K
MO icon
50
Altria Group
MO
$114B
$1.8M 0.69%
45,886
-254
-0.6% -$9.91K

Similar funds

Kavar Capital Partners Group's Q2 2020 Portfolio in Review

As of Q2 2020, Kavar Capital Partners Group held 129 positions worth $260M, up 25% from $209M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Kavar Capital Partners Group deployed $17.3M of net new capital in Q2 2020, opening 12 new positions and adding to 42 existing holdings. Its largest new stake was Walmart Inc: 18,270 shares worth $729K.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Focus Financial Partners Inc. Class A, an estimated $170K trimmed.

  • Kavar Capital Partners Group's largest Q2 2020 buy was Walmart Inc: 18,270 shares worth $729K.
  • Kavar Capital Partners Group added most to Vanguard Morningstar Small-Cap Value ETF in Q2 2020, an estimated $6.49M increase.
  • Kavar Capital Partners Group's biggest Q2 2020 reduction was Focus Financial Partners Inc. Class A, cutting an estimated $170K.
  • Kavar Capital Partners Group fully exited Global Payments in Q2 2020, selling an estimated $303K.
  • Kavar Capital Partners Group's ten largest holdings make up 34% of its $260M portfolio in Q2 2020.
  • Kavar Capital Partners Group opened 12 new positions and closed 8 in Q2 2020.
  • Kavar Capital Partners Group's portfolio value rose 25% quarter-over-quarter to $260M.

Based on Kavar Capital Partners Group's 13F filing for Q2 2020, filed 23 Jul 2020.